Savior Lifetec (4167) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Based on the latest financial reports, Savior Lifetec (4167) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-98.65 Million ≈ $-3.11 Million USD) by net assets (NT$3.78 Billion ≈ $119.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Savior Lifetec to measure how much of total assets are equity-financed.

Savior Lifetec - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Savior Lifetec's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Savior Lifetec (4167) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Savior Lifetec Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Savior Lifetec ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Xi S And D Inc
KO:317400
0.017x
Huons Global Co. Ltd
KQ:084110
0.027x
A Paradise Acquisition Corp.
NYSE:APAD
-0.001x
Oriola-KD Oyj B
HE:OKDBV
0.229x
Gobarto S.A.
WAR:GOB
0.057x
Taylor Devices Inc
NASDAQ:TAYD
0.013x
Deutsche Konsum REIT AG
XETRA:DKG
0.000x
Platinum Group Metals Ltd
TO:PTM
-0.014x

Annual Cash Flow Conversion Efficiency for Savior Lifetec (2011–2025)

The table below shows the annual cash flow conversion efficiency of Savior Lifetec from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Savior Lifetec worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$3.78 Billion
≈ $119.12 Million
NT$-21.04 Million
≈ $-662.91K
-0.006x -103.77%
2024-12-31 NT$3.52 Billion
≈ $110.78 Million
NT$518.38 Million
≈ $16.33 Million
0.147x +27.87%
2023-12-31 NT$3.36 Billion
≈ $106.01 Million
NT$387.95 Million
≈ $12.22 Million
0.115x -33.27%
2022-12-31 NT$3.37 Billion
≈ $106.08 Million
NT$581.77 Million
≈ $18.33 Million
0.173x +440.04%
2021-12-31 NT$3.31 Billion
≈ $104.37 Million
NT$-168.34 Million
≈ $-5.30 Million
-0.051x -285.45%
2020-12-31 NT$3.33 Billion
≈ $104.92 Million
NT$91.25 Million
≈ $2.87 Million
0.027x -61.21%
2019-12-31 NT$2.21 Billion
≈ $69.75 Million
NT$156.40 Million
≈ $4.93 Million
0.071x +169.06%
2018-12-31 NT$1.86 Billion
≈ $58.47 Million
NT$-189.84 Million
≈ $-5.98 Million
-0.102x -184.82%
2017-12-31 NT$2.16 Billion
≈ $68.15 Million
NT$260.89 Million
≈ $8.22 Million
0.121x +435.93%
2016-12-31 NT$2.12 Billion
≈ $66.77 Million
NT$-76.09 Million
≈ $-2.40 Million
-0.036x +86.25%
2015-12-31 NT$1.59 Billion
≈ $50.15 Million
NT$-415.82 Million
≈ $-13.10 Million
-0.261x -265.61%
2014-12-31 NT$1.29 Billion
≈ $40.75 Million
NT$-92.41 Million
≈ $-2.91 Million
-0.071x -16.66%
2013-12-31 NT$1.39 Billion
≈ $43.93 Million
NT$-85.39 Million
≈ $-2.69 Million
-0.061x +65.70%
2012-12-31 NT$1.27 Billion
≈ $40.16 Million
NT$-227.59 Million
≈ $-7.17 Million
-0.179x +48.89%
2011-12-31 NT$1.31 Billion
≈ $41.38 Million
NT$-458.82 Million
≈ $-14.46 Million
-0.349x --

About Savior Lifetec

TWO:4167 Taiwan Biotechnology
Market Cap
$165.29 Million
NT$5.25 Billion TWD
Market Cap Rank
#17215 Global
#846 in Taiwan
Share Price
NT$16.90
Change (1 day)
+1.20%
52-Week Range
NT$16.70 - NT$21.85
All Time High
NT$40.63
About

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, mero… Read more